Hypertension and targeted therapy: Part 2: Small molecule inhibitors of VEGF

Author： Chowdhury Simon  

Publisher： Springer Publishing Company

ISSN： 1776-2596

Source： Targeted Oncology, Vol.1, Iss.3, 2006-07, pp. : 172-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 20-30

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RSK: An Overview of Small Molecule Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 710-716

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Small Molecule Prodrugs for Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 3, 2014-03 ,pp. : 418-439

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

By Schlaeppi J-M.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 473-481

Springer Publishing Company

Access to resources Recommend Favorite

Small Molecule Signal Transduction Inhibitors for the Treatment of Solid Tumors

By Leary Alexandra   Johnston Stephen R. D.  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 347-365

Informa Healthcare

Access to resources Recommend Favorite